Giant Cell Arteritis (GCA): Clinical Trials

28 trials for Giant Cell Arteritis (GCA), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 recruiting, 9 not yet recruiting, 4 completed, 1 enrolling by invitation. 4 Not applicable, 4 Phase 3, 3 Phase 2, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable4Not yet recruiting 2, Recruiting 2
Phase 34Completed 2, Not yet recruiting 2
Phase 23Recruiting 2, Not yet recruiting 1
Phase 42Enrolling by invitation 1, Recruiting 1

Follow Giant Cell Arteritis (GCA): new trials by email Literature Review of Giant Cell Arteritis (GCA) trials Research Report on Giant Cell Arteritis (GCA)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aspirin for the Prevention of Ischemic Complications in Giant Cell Arteritis
Acetyl Salicylic Acid (ASA), Placebo - Giant Cell Arteritis (GCA), Acute Coronary Syndrome (ACS)
Phase 3Not yet recruitingCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal1202027-10-012026-10-30
Long-Axial Field of View (LAFOV) [18F]FDG PET/CT Imaging in Large Vessel Vasculitis (LVV): Protocol Optimisation Study.
[18F]FDG Long-Axial Field of View (LAFOV)-PET/CT, CT Angiogram, MR Angiogram - Large Vessel Vasculitis, Takayasu Arteritis
Not applicableNot yet recruitingImperial College London182026-12-012026-10-16
Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA)
Zirconium Zr 89 labelled rituximab - Giant Cell Arteritis (GCA)
Not yet recruitingUniversity of Edinburgh302026-10-012026-06-16
Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone
Prednisone - Giant Cell Arteritis (GCA)
Phase 3Not yet recruitingInsel Gruppe AG, University Hospital Bern1782026-07-012026-05-01
Kinetics of C-Reactive Protein in Giant Cell Arteritis Following Glucocorticoid Initiation: A Pilot Study (GIDEON)
Blood tests to measure CRP - Giant Cell Arteritis (GCA)
Not applicableNot yet recruitingUniversity Hospital, Limoges402026-06-222026-07-22
Bosentan in the Treatment of Giant Cell Arteritis
Bosentan, Glucocorticoids - Giant Cell Arteritis (GCA)
Phase 2Not yet recruitingAssistance Publique - Hôpitaux de Paris402026-06-012026-05-06
Disease Activity Monitoring in Patients With Giant Cell Arteritis Study
Giant Cell Arteritis (GCA)
RecruitingUniversity of Aarhus1752026-05-062026-08-31
The VGR GCA Cohort: Ultrasound, Biopsy and Biomarkers - Novel Methods for Diagnosis, Monitoring and Prognosis in Giant Cell Arteritis.
Giant Cell Arteritis (GCA)
RecruitingVastra Gotaland Region3402026-03-012026-04-15
Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.
Giant Cell Arteritis (GCA)
Not yet recruitingGroupe français d'étude des Maladies Inflammatoires de loeil802026-03-012026-01-21
Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients
Doppler Ultrasound - Giant Cell Arteritis (GCA), Doppler Ultrasound
Not applicableRecruitingCentre Hospitalier le Mans642026-02-272026-07-17
Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica
Description of population - Giant Cell Arteritis (GCA), Spondylarthritis
Not yet recruitingHôpital NOVO102026-02-012026-02-06
Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis
Positron Emission Tomography / Magnetic Resonance Imaging - Giant Cell Arteritis (GCA), Ischemic Optic Neuropathy
RecruitingCopenhagen University Hospital, Rigshospitalet1222026-01-142026-05-07
Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis
Tocilizumab, Discontinue Tocilizumab - Giant Cell Arteritis (GCA)
Phase 2RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)782026-01-052026-08-10
oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound
orbital ultrasound - Giant Cell Arteritis (GCA)
Not applicableRecruitingHôpital NOVO1902025-09-042025-09-12
Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Ex Vivo Assay - Rheumatic Diseases, Rheumatoid Arthritis (RA)
RecruitingUniversity of Bonn1202025-04-012025-09-02
Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)
Bosentan and dapagliflozin - Large Vessel Vasculitis, Giant Cell Arteritis (GCA)
Phase 2RecruitingUniversity of Edinburgh602025-03-212026-01-14
Performance of a Fast-track Pathway for Giant Cell Arteritis Diagnosis
Giant Cell Arteritis (GCA)
RecruitingGroupe Hospitalier de la Rochelle Ré Aunis1002025-02-142025-06-20
A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA)
Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine100002025-01-302025-01-09
Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases
Shingrix, vaccination with 2 doses of Shingrix vaccine - Systemic Vasculitis, Spondylarthropathies
Phase 4Enrolling by invitationRegion Skane2402024-12-172025-01-10
AYLo - AutoimmunitY and Loss of y
Single nucleotide polymorphisms (SNP), 3'mRNA sequencing, Enzyme-linked immunosorbent assay (ELISA) and Legendplex Array - Giant Cell Arteritis (GCA), Polymyalgia Rheumatica (PMR)
RecruitingUniversity of Bonn5002024-11-152025-04-10

Showing 20 of 28. Sign in to see all of them.

Narrower conditions

Giant Cell Arteritis (28)  ·  Polymyalgia Rheumatica (8)  ·  Arthritis, Psoriatic (4)  ·  Takayasu Arteritis (3)  ·  Vasculitis (3)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2)  ·  Arthritis, Juvenile (2)  ·  Arthritis, Rheumatoid (2)  ·  Cardiovascular Diseases (2)  ·  Connective Tissue Diseases (2)  ·  Myositis (2)  ·  Acute Coronary Syndrome (1)  ·  Adrenal Insufficiency (1)  ·  Aortitis (1)  ·  Arthritis (1)

Broader conditions

Arteritis (28)  ·  Autoimmune Diseases of the Nervous System (28)  ·  Brain Diseases (28)  ·  Central Nervous System Diseases (28)  ·  Cerebrovascular Disorders (28)  ·  Immune System Diseases (28)  ·  Nervous System Diseases (28)  ·  Skin Diseases (28)  ·  Skin Diseases, Vascular (28)  ·  Skin and Connective Tissue Diseases (28)  ·  Vascular Diseases (28)  ·  Vasculitis, Central Nervous System (28)  ·  Autoimmune Diseases (27)  ·  Cardiovascular Diseases (26)  ·  Vasculitis (25)

Interventions

Bosentan (2)  ·  Adrenal Cortex Hormones (1)  ·  Data Collection (1)  ·  Flow Cytometry (1)  ·  Glucocorticoids (1)  ·  Hydrocortisone (1)  ·  Magnetic Resonance Imaging (1)  ·  Polymorphism, Single Nucleotide (1)  ·  Positron-Emission Tomography (1)  ·  Prednisone (1)  ·  Tomography, Optical Coherence (1)  ·  Vaccination (1)  ·  dapagliflozin (1)  ·  secukinumab (1)  ·  tocilizumab (1)

Sponsors

Groupe français d'étude des Maladies Inflammatoires de loeil (3)  ·  Hôpital NOVO (2)  ·  University of Bonn (2)  ·  University of Edinburgh (2)  ·  AbbVie (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Centre Hospitalier Universitaire Dijon (1)  ·  Centre Hospitalier le Mans (1)  ·  Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Groupe Hospitalier de la Rochelle Ré Aunis (1)  ·  Imperial College London (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Marianne Andersen (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

France (11)  ·  Denmark (5)  ·  Germany (5)  ·  United Kingdom (5)  ·  Sweden (4)  ·  Switzerland (4)  ·  Canada (3)  ·  United States (3)  ·  Australia (2)  ·  Austria (2)  ·  Belgium (2)  ·  Czechia (2)  ·  Greece (2)  ·  Hungary (2)  ·  Israel (2)

Top investigators

Alexander Isaak, PD Dr. (1)  ·  Jean-Paul Makhzoum, MD (1)  ·  Julian Luetkens, Prof. Dr. (1)  ·  Lisa Christ, Dr. med. (1)  ·  Marianne S Andersen (1)  ·  Sebastian H Unizony, M.D. (1)  ·  Simon Petzinna, Dr. (1)  ·  Tara D Barwick, MBChB MSc FRCR FRCP (1)

Results publications

PMID 26952547, PMID 28745999, PMID 28756037, PMID 30392702, PMID 31270110, PMID 36508210, PMID 38840219, PMID 40174237, PMID 41537566, PMID 41638742, PMID 42234457, PMID 42667206

NIH funding

2023 (2), 2017 (1), 2025 (1)